Perioperative β-blocker withdrawal and mortality in vascular surgical patients

Jonathan B. Shammash, Jeff Trost, Julie M. Gold, Jesse A. Berlin, Michael A. Golden, Stephen E. Kimmel

Research output: Contribution to journalArticle

Abstract

Objective: Our purpose was to determine the effect of postoperative β-blocker withdrawal on mortality and cardiovascular events after vascular surgery. Methods: Detailed data were collected on perioperative cardiovascular medication use and discontinuation and cardiovascular risk factors among consecutive major vascular surgical procedures at two university hospitals. Results: A total of 140 patients received β-blockers preoperatively. Mortality in the 8 patients who had β-blockers discontinued postoperatively (50%) was significantly greater than in 132 patients who had β-blockers continued (1.5%, odds ratio 65.0, P <.001). The effect of β-blocker discontinuation was unaffected by adjustment by stratification for risk factors (all P ≤ .01), for contraindications to restarting β-blockers (P = .006), and by multivariable analyses adjusting for potential confounders (adjusted odds ratio 17.0, P = .01). β-Blocker discontinuation also was associated with increased cardiovascular mortality (0% vs 29%, P = .005) and postoperative myocardial infarction (odds ratio 17.7, P = .003). Conclusion: Discontinuing β-blockers immediately after vascular surgery may increase the risk of postoperative cardiovascular morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)148-153
Number of pages6
JournalAmerican Heart Journal
Volume141
Issue number1
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Blood Vessels
Mortality
Odds Ratio
Vascular Surgical Procedures
Myocardial Infarction
Morbidity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Shammash, J. B., Trost, J., Gold, J. M., Berlin, J. A., Golden, M. A., & Kimmel, S. E. (2001). Perioperative β-blocker withdrawal and mortality in vascular surgical patients. American Heart Journal, 141(1), 148-153. https://doi.org/10.1067/mhj.2001.111547

Perioperative β-blocker withdrawal and mortality in vascular surgical patients. / Shammash, Jonathan B.; Trost, Jeff; Gold, Julie M.; Berlin, Jesse A.; Golden, Michael A.; Kimmel, Stephen E.

In: American Heart Journal, Vol. 141, No. 1, 2001, p. 148-153.

Research output: Contribution to journalArticle

Shammash, JB, Trost, J, Gold, JM, Berlin, JA, Golden, MA & Kimmel, SE 2001, 'Perioperative β-blocker withdrawal and mortality in vascular surgical patients', American Heart Journal, vol. 141, no. 1, pp. 148-153. https://doi.org/10.1067/mhj.2001.111547
Shammash, Jonathan B. ; Trost, Jeff ; Gold, Julie M. ; Berlin, Jesse A. ; Golden, Michael A. ; Kimmel, Stephen E. / Perioperative β-blocker withdrawal and mortality in vascular surgical patients. In: American Heart Journal. 2001 ; Vol. 141, No. 1. pp. 148-153.
@article{572283338b8b4dd0a4896fb32acb39ef,
title = "Perioperative β-blocker withdrawal and mortality in vascular surgical patients",
abstract = "Objective: Our purpose was to determine the effect of postoperative β-blocker withdrawal on mortality and cardiovascular events after vascular surgery. Methods: Detailed data were collected on perioperative cardiovascular medication use and discontinuation and cardiovascular risk factors among consecutive major vascular surgical procedures at two university hospitals. Results: A total of 140 patients received β-blockers preoperatively. Mortality in the 8 patients who had β-blockers discontinued postoperatively (50{\%}) was significantly greater than in 132 patients who had β-blockers continued (1.5{\%}, odds ratio 65.0, P <.001). The effect of β-blocker discontinuation was unaffected by adjustment by stratification for risk factors (all P ≤ .01), for contraindications to restarting β-blockers (P = .006), and by multivariable analyses adjusting for potential confounders (adjusted odds ratio 17.0, P = .01). β-Blocker discontinuation also was associated with increased cardiovascular mortality (0{\%} vs 29{\%}, P = .005) and postoperative myocardial infarction (odds ratio 17.7, P = .003). Conclusion: Discontinuing β-blockers immediately after vascular surgery may increase the risk of postoperative cardiovascular morbidity and mortality.",
author = "Shammash, {Jonathan B.} and Jeff Trost and Gold, {Julie M.} and Berlin, {Jesse A.} and Golden, {Michael A.} and Kimmel, {Stephen E.}",
year = "2001",
doi = "10.1067/mhj.2001.111547",
language = "English (US)",
volume = "141",
pages = "148--153",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Perioperative β-blocker withdrawal and mortality in vascular surgical patients

AU - Shammash, Jonathan B.

AU - Trost, Jeff

AU - Gold, Julie M.

AU - Berlin, Jesse A.

AU - Golden, Michael A.

AU - Kimmel, Stephen E.

PY - 2001

Y1 - 2001

N2 - Objective: Our purpose was to determine the effect of postoperative β-blocker withdrawal on mortality and cardiovascular events after vascular surgery. Methods: Detailed data were collected on perioperative cardiovascular medication use and discontinuation and cardiovascular risk factors among consecutive major vascular surgical procedures at two university hospitals. Results: A total of 140 patients received β-blockers preoperatively. Mortality in the 8 patients who had β-blockers discontinued postoperatively (50%) was significantly greater than in 132 patients who had β-blockers continued (1.5%, odds ratio 65.0, P <.001). The effect of β-blocker discontinuation was unaffected by adjustment by stratification for risk factors (all P ≤ .01), for contraindications to restarting β-blockers (P = .006), and by multivariable analyses adjusting for potential confounders (adjusted odds ratio 17.0, P = .01). β-Blocker discontinuation also was associated with increased cardiovascular mortality (0% vs 29%, P = .005) and postoperative myocardial infarction (odds ratio 17.7, P = .003). Conclusion: Discontinuing β-blockers immediately after vascular surgery may increase the risk of postoperative cardiovascular morbidity and mortality.

AB - Objective: Our purpose was to determine the effect of postoperative β-blocker withdrawal on mortality and cardiovascular events after vascular surgery. Methods: Detailed data were collected on perioperative cardiovascular medication use and discontinuation and cardiovascular risk factors among consecutive major vascular surgical procedures at two university hospitals. Results: A total of 140 patients received β-blockers preoperatively. Mortality in the 8 patients who had β-blockers discontinued postoperatively (50%) was significantly greater than in 132 patients who had β-blockers continued (1.5%, odds ratio 65.0, P <.001). The effect of β-blocker discontinuation was unaffected by adjustment by stratification for risk factors (all P ≤ .01), for contraindications to restarting β-blockers (P = .006), and by multivariable analyses adjusting for potential confounders (adjusted odds ratio 17.0, P = .01). β-Blocker discontinuation also was associated with increased cardiovascular mortality (0% vs 29%, P = .005) and postoperative myocardial infarction (odds ratio 17.7, P = .003). Conclusion: Discontinuing β-blockers immediately after vascular surgery may increase the risk of postoperative cardiovascular morbidity and mortality.

UR - http://www.scopus.com/inward/record.url?scp=0035161306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035161306&partnerID=8YFLogxK

U2 - 10.1067/mhj.2001.111547

DO - 10.1067/mhj.2001.111547

M3 - Article

C2 - 11136500

AN - SCOPUS:0035161306

VL - 141

SP - 148

EP - 153

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 1

ER -